- Corporate Officers - S
- Sanofi
Insider Trading History of Sanofi
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sanofi since 2015.
This trader's CIK number is 1121404.
At the time of last reporting, Sanofi was the Officer of Attovia Therapeutics, Inc.. (stock ticker symbol ATTO).
Also see all insider trading activities at Attovia Therapeutics, Inc..
Note that in the past
Sanofi also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Icosavax, Inc. (ICVX) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ICVX | 66,667 | $1,000,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | FULC | 93,750 | $1,500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inozyme Pharma, Inc. (INZY) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | INZY | 81,250 | $1,300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Myokardia, Inc. (MYOK) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MYOK | 0 | $0 | 4,168,899 | $157,000,736 | 0 | $0 |
| 2018 | MYOK | 150,000 | $7,350,000 | 0 | $0 | 0 | $0 |
| 2017 | MYOK | 350,000 | $12,425,000 | 0 | $0 | 0 | $0 |
| 2016 | MYOK | 450,000 | $6,750,000 | 0 | $0 | 0 | $0 |
| 2015 | MYOK | 900,000 | $9,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | REGN | 0 | $0 | 23,070,599 | $11,770,477,328 | 0 | $0 |
| 2019 | REGN | 0 | $0 | 304,019 | $102,653,062 | 0 | $0 |
| 2018 | REGN | 0 | $0 | 226,153 | $80,131,125 | 0 | $0 |
| 2017 | REGN | 462,141 | $212,021,764 | 0 | $0 | 0 | $0 |
| 2016 | REGN | 148,669 | $62,482,433 | 0 | $0 | 0 | $0 |
| 2015 | REGN | 249,426 | $126,235,455 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Attovia Therapeutics, Inc. (ATTO) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | ATTO | 300,000 | $5,100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ALNY | 297,501 | $21,381,396 | 0 | $0 | 0 | $0 |
| 2016 | ALNY | 205,030 | $14,300,842 | 0 | $0 | 0 | $0 |
| 2015 | ALNY | 940,817 | $1,899,204,337 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Voyager Therapeutics, Inc. (VYGR) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | VYGR | 125,000 | $1,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Sanofi
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TBIO | 71,983,597 | $2,735,376,686 | 0 | $0 | 0 | $0 |
Insider trading activities at 9 companies by Sanofi:
1. Icosavax, Inc. (ICVX)
2. Fulcrum Therapeutics, Inc. (FULC)
3. Inozyme Pharma, Inc. (INZY)
4. Myokardia, Inc. (MYOK)
5. Regeneron Pharmaceuticals, Inc. (REGN)
6. Attovia Therapeutics, Inc. (ATTO)
7. Alnylam Pharmaceuticals, Inc. (ALNY)
8. Voyager Therapeutics, Inc. (VYGR)
9. Translate Bio, Inc. (TBIO)
Table 1. Insider trading of Icosavax, Inc. (ICVX) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-08-02 | ICVX | Buy | 66,667 | 15.00 | 1,000,005 |
Table 2. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-22 | FULC | Buy | 93,750 | 16.00 | 1,500,000 |
Table 3. Insider trading of Inozyme Pharma, Inc. (INZY) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-28 | INZY | Buy | 81,250 | 16.00 | 1,300,000 |
Table 4. Insider trading of Myokardia, Inc. (MYOK) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-13 | MYOK | Sale | 4,168,899 | 37.66 | 157,000,736 |
| 2018-05-25 | MYOK | Buy | 150,000 | 49.00 | 7,350,000 |
| 2017-08-14 | MYOK | Buy | 350,000 | 35.50 | 12,425,000 |
| 2016-10-03 | MYOK | Buy | 450,000 | 15.00 | 6,750,000 |
| 2015-11-03 | MYOK | Buy | 900,000 | 10.00 | 9,000,000 |
Table 5. Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-09 | REGN | Sale | 120,234 | 597.48 | 71,837,410 |
| 2020-05-29 | REGN | Sale | 22,821,451 | 509.85 | 11,635,516,792 |
| 2020-03-09 | REGN | Sale | 128,914 | 489.65 | 63,123,126 |
| 2019-09-10 | REGN | Sale | 172,904 | 281.15 | 48,611,786 |
| 2019-03-08 | REGN | Sale | 131,115 | 412.17 | 54,041,276 |
| 2018-09-06 | REGN | Sale | 104,552 | 406.68 | 42,519,207 |
| 2018-06-08 | REGN | Sale | 121,601 | 309.31 | 37,611,918 |
| 2017-08-25 | REGN | Buy | 72,378 | 482.99 | 34,957,488 |
| 2017-08-23 | REGN | Buy | 60,595 | 478.30 | 28,982,467 |
| 2017-08-24 | REGN | Buy | 105,820 | 481.79 | 50,983,335 |
| 2017-06-02 | REGN | Buy | 136,050 | 475.63 | 64,709,869 |
| 2017-01-11 | REGN | Buy | 87,298 | 371.01 | 32,388,605 |
| 2016-06-14 | REGN | Buy | 64,731 | 364.22 | 23,576,583 |
| 2016-01-12 | REGN | Buy | 83,938 | 463.51 | 38,905,850 |
| 2015-10-06 | REGN | Buy | 11,040 | 473.60 | 5,228,532 |
| 2015-10-06 | REGN | Buy | 80,538 | 459.17 | 36,980,633 |
| 2015-09-23 | REGN | Buy | 147,209 | 532.00 | 78,315,924 |
| 2015-07-27 | REGN | Buy | 10,639 | 536.74 | 5,710,366 |
Table 6. Insider trading of Attovia Therapeutics, Inc. (ATTO) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-08-06 | ATTO | Buy | 300,000 | 17.00 | 5,100,000 |
Table 7. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-31 | ALNY | Buy | 297,501 | 71.87 | 21,381,396 |
| 2016-02-01 | ALNY | Buy | 205,030 | 69.75 | 14,300,842 |
| 2015-01-29 | ALNY | Buy | 97,118 | 95.00 | 9,226,210 |
| 2015-01-22 | ALNY | Buy | 196,251 | 9,317.00 | 1,828,470,567 |
| 2015-01-26 | ALNY | Buy | 647,448 | 95.00 | 61,507,560 |
Table 8. Insider trading of Voyager Therapeutics, Inc. (VYGR) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-11-16 | VYGR | Buy | 125,000 | 14.00 | 1,750,000 |
Table 9. Insider trading of Translate Bio, Inc. (TBIO) by Sanofi
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-14 | TBIO | Buy | 71,983,597 | 38.00 | 2,735,376,686 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sanofi
(Officer of Attovia Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.